Chemotherapy related fatal neurotoxicity during induction in acute lymphoblastic leukemia

Indian Journal of Pediatrics

Volumn 69, Issue 2, 2002, Pages 185-187

  Ray, Munni ^a   Marwaha, R K ^a   Trehan, Amita ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Acute leukemia; Chemotherapy; Fatal neurotoxicity

Indexed keywords

2 AMINO 4 (METHYLSULFONYL)BUTYRYLGLUTAMYLHISTIDYLPHENYLALANYL DEXTRO LYSYLPHENYLALANINE; ASPARAGINASE; ASPARTIC ACID; CYANOCOBALAMIN; DEXAMETHASONE; FOLINIC ACID; GANGLIOSIDE; GLUTAMIC ACID; LITHIUM; METHOTREXATE; PHENYTOIN; PYRIDOXINE; THIAMINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CHILD; CRANIAL NERVE PARALYSIS; DRUG FATALITY; DRUG INDUCED DISEASE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERCOAGULABILITY; LIVER DYSFUNCTION; MALE; NEUROTOXICITY; REMISSION; SEIZURE;

EID: 0036118986     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02859383     Document Type: Article

References (17)

1. Craft AW. Childhood cancer - mainly curable so where next? Acta Pediatr 2000; 89 : 386-393.
2. Macdonald DR. Neurologic complications of chemotherapy. Neurol Clin 1991; 9 : 955-967.
3. Campbell RH, Marshall WC, Chessells JM. Neurological complications of childhood leukaemia. Arch Dis Child 1977; 52 : 850-858.
4. Dimario Jr. FJ, Packer RJ. Acute mental status changes in children with systemic cancer. Pediatrics 1990; 85 : 353-360.
5. Mena H, Garcia JH, Velandia F. Central peripheral myelinopathy associated with systemic neoplasia and chemotherapy. Cancer 1981; 48 : 1724-1737.
6. Legha SS. Vincristine neurotoxicity. Pathophysiology and management. Med Toxicol 1986; 1: 421-427.
7. Sandler SG, Tobin W, Henderson S. Vincristine induced neuropathy. Neurology 1969; 19 : 367-374.
8. McCarthy GM, Skilling JR. A prospective cohort study of the orofacial effects of vincristine neurotoxicity. J Oral Pathol 1991; 20 : 345-349.
9. Soysal T, Ferhanoglu T, Bilir A, Akman L. Oculomotor nerve palsy associated with vincristine treatment. Acta Haematol 1993; 90 : 209-210.
10. Byrd RL, Rohrbaugh TM, Raney RB Jr, Norris DG. Transient cortical blindness secondary to vincristine therapy in childhood malignancies. Cancer 1981; 47 : 37-40.
11. Desai ZR, VandenBerg HW, Bridges JM, Shanks RG. Can severe neurotoxicity be prevented? Cancer Chemother Pharmacol 1982; 8 : 211-214.
12. Jackson DV, Wells HB, Atkins JN, Zekan PJ, White DR, Richards F, Cruz JM, Muss HB. Amelioration of vincristine neurotoxicity by glutamic acid. Am J Med 1988; 84 : 1016-1022.
13. Houi H, Mochio S, Kobayashi T. Gangliosides attenuate vincristine neurotoxicity on dorsal root ganglion cells. Muscle Nerve 1993; 16 : 11-14.
14. Kiburg B, Moorer van Delft CM, Heimans JJ, Hujgens PC, Boer HH. In vivo modulation of vincristine induced neurotoxicity in Lymnaea stagnalis, by the ACTH analogue Org 2766. J Neuro Oncol 1996; 30 : 173-180.
15. Young SB. Nursing considerations in caring for the child with vincristine induced neurotoxicities. J Pediatr Oncol Nurs 1990; 7 : 9-13
16. Winick NJ, Bowman WP, Kamen BA, Roach ES, Rollins N, Jacaruso D, Buchanan GR. Unexpected acute neurologic toxicity in the treatment of children with acute lymphoblastic leukemia. J Natl Cancer Inst 1992; 84 : 252-256.
17. Chen CY, Zimmerman RA, Faro S, Bilniuk LT, Chou TY, Molloy PT. Childhood leukemia: central nervous system abnormalities during and after treatment. Am J Neuroradiol 1996; 17 : 295-310.